Research Article
Impact of Insurance Coverage on Outcomes in Primary Breast Sarcoma
Table 4
Univariate and multivariate Cox proportional hazard models.
| Variable | Univariate analysis | Multivariate analysis | HR (95% CI) | | HR (95% CI) | |
| Insurance coverage | | | | | Private | Reference | | Reference | | Medicaid | 3.01 (2.04–4.45) | <0.001 | 2.47 (1.62–3.77) | <0.001 | Medicare | 2.55 (1.94–3.33) | <0.001 | 1.68 (1.10–2.57) | 0.017 | Age (years) | | | | | 18–44 | Reference | | Reference | | 45–54 | 1.34 (0.87–2.06) | 0.187 | 1.20 (0.76–1.89) | 0.435 | 55–64 | 1.34 (0.86–2.08) | 0.194 | 1.52 (0.95–2.43) | 0.081 | ≥65 | 2.40 (1.65–3.50) | <0.001 | 2.03 (1.20–3.43) | 0.008 | Race | | | | | White | Reference | | Reference | | Black | 0.90 (0.63–1.27) | 0.543 | 0.65 (0.43–0.98) | 0.040 | Other/unknown | 0.43 (0.23–0.81) | 0.009 | 0.45 (0.24–0.87) | 0.018 | Year of diagnosis | | | | | 2004-2005 | Reference | | Reference | | 2006-2007 | 0.80 (0.54–1.18) | 0.256 | 0.70 (0.47–1.06) | 0.095 | 2008-2009 | 1.31 (0.92–1.87) | 0.130 | 1.04 (0.71–1.51) | 0.843 | 2010-2011 | 1.27 (0.87–1.86) | 0.220 | 0.68 (0.44–1.03) | 0.066 | 2012-2013 | 0.94 (0.60–1.49) | 0.802 | 0.74 (0.46–1.18) | 0.207 | Charlson–Deyo score | | | | | 0 | Reference | | Reference | | 1 | 1.19 (0.86–1.66) | 0.291 | 1.13 (0.77–1.63) | 0.535 | ≥2 | 3.28 (1.67–6.42) | 0.001 | 1.40 (0.68–2.92) | 0.363 | Income | | | | | <$38,000 | Reference | | Reference | | ≥$38,000 | 0.77 (0.57–1.05) | 0.099 | 0.95 (0.65–1.39) | 0.795 | Residence type | | | | | Metropolitan | Reference | | Reference | | Urban/rural | 1.21 (0.85–1.72) | 0.282 | 1.01 (0.67–1.53) | 0.956 | Distance from facility | | | | | ≤50 miles | Reference | | Reference | | >50 miles | 0.93 (0.61–1.43) | 0.741 | 0.72 (0.45–1.16) | 0.179 | Educational attainment (% without HSD) | | | | | ≥13% | Reference | | Reference | | <13% | 0.87 (0.67–1.11) | 0.255 | 0.89 (0.66–1.19) | 0.415 | Angiosarcoma | | | | | Yes | Reference | | Reference | | No | 0.96 (0.74–1.24) | 0.755 | 0.82 (0.62–1.10) | 0.183 | Tumor size category | | | | | T1: ≤5 cm | Reference | | Reference | | T2: >5 cm | 3.26 (2.47–4.30) | <0.001 | 3.66 (2.66–5.02) | <0.001 | Unknown | 1.72 (1.08–2.74) | 0.022 | 1.56 (0.95–2.54) | 0.079 | Node status | | | | | N0 | Reference | | Reference | | N+ | 1.54 (0.75–3.16) | 0.239 | 1.43 (0.67–3.06) | 0.348 | No nodes examined/unknown | 0.98 (0.76–1.26) | 0.880 | 0.92 (0.70–1.23) | 0.586 | Metastatic status | | | | | M0 | Reference | | Reference | | M1 | 7.20 (5.19–10.00) | <0.001 | 7.19 (4.69–11.03) | <0.001 | Grade | | | | | G1: well differentiated | Reference | | Reference | | G2: moderately differentiated | 1.36 (0.78–2.38) | 0.280 | 1.49 (0.83–2.69) | 0.181 | G3: poorly, undifferentiated, or anaplastic | 2.67 (1.74–4.12) | <0.001 | 2.23 (1.39–3.58) | 0.001 | Unknown | 2.04 (1.25–3.30) | 0.004 | 1.89 (1.14–3.13) | 0.014 | Treatment summary | | | | | No definitive treatment | Reference | | Reference | | Surgery alone | 0.31 (0.18–0.53) | <0.001 | 0.20 (0.11–0.37) | <0.001 | Surgery and RT | 0.27 (0.15–0.47) | <0.001 | 0.12 (0.06–0.23) | <0.001 | Other/unknown | 0.60 (0.34–1.07) | 0.083 | 0.22 (0.11–0.43) | <0.001 |
|
|
Abbreviations: HR, hazard ratio; CI, confidence interval; HSD, high school degree; RT, radiation therapy.
|